We found generally stronger associations for receptor-positive subtypes (particularly PR+) for both premenopausal and postmenopausal BC, but these differences were only statistically significant in postmenopausal BC, possibly due to lower numbers of premenopausal BCs. Here, PGR is linked to breast cancer.